Orbit Discovery Company
Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases. Peptides offer the potential to make drugs with the specificity and efficacy of large biologic molecules combined with the smaller dose size, simpler routes of delivery and lower cost of manufacturing found with small molecules. They are, therefore, uniquely suited to the treatment of chronic diseases which impact large patient populations. Their technology supports all of the improvements that can be made to peptides which make them better drugs whilst simplifying the discovery process and accelerating drug development
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
PharmTech
Number Of Exists:
N/A
Technology:
Drug Delivery
Founded Date:
2015
Investor Type:
N/A
Headquarters:
Oxford, Oxfordshire, United Kingdom
Employee Number:
11-50
Investment Stage:
N/A